Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -93.66%25.85M | ---- | -82.99%407.51M | ---- | 757.07%2.4B | ---- | 85.46%-364.7M | ---- | -1,633.77%-2.51B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -67.83%-13.96M | ---- | -16.55%-8.32M | ---- | -8.15%-7.14M | ---- | 31.47%-6.6M | ---- | 11.92%-9.63M |
| Investment loss (gain) | ---- | 20.34%-26.83M | ---- | -0.14%-33.68M | ---- | 32.78%-33.63M | ---- | -22.75%-50.04M | ---- | 14.08%-40.76M |
| Impairment and provisions: | ---- | 81.86%128.51M | ---- | 217.19%70.66M | ---- | -85.97%22.28M | ---- | -92.99%158.74M | ---- | 489.01%2.26B |
| -Impairment of property, plant and equipment (reversal) | ---- | --10.99M | ---- | ---- | ---- | ---- | ---- | --14.48M | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.94%396.46M |
| -Other impairments and provisions | ---- | 66.31%117.52M | ---- | 217.19%70.66M | ---- | -84.56%22.28M | ---- | -92.27%144.26M | ---- | 6,354.93%1.87B |
| Revaluation surplus: | ---- | 94.17%210.25M | ---- | 468.73%108.28M | ---- | -88.54%19.04M | ---- | -15.11%166.13M | ---- | 28.52%195.71M |
| -Fair value of investment properties (increase) | ---- | 94.17%210.25M | ---- | 468.73%108.28M | ---- | -88.54%19.04M | ---- | -15.11%166.13M | ---- | 28.52%195.71M |
| Asset sale loss (gain): | ---- | 104.62%5.83M | ---- | 94.05%-126.29M | ---- | -12,172.73%-2.12B | ---- | -1,720.51%-17.31M | ---- | -2.29%1.07M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 104.62%5.83M | ---- | -40,064.87%-126.29M | ---- | 101.83%316K | ---- | -1,720.51%-17.31M | ---- | -2.29%1.07M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---2.12B | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 2.46%99.67M | ---- | 11.54%97.28M | ---- | 2.49%87.21M | ---- | 14.29%85.1M | ---- | -15.41%74.46M |
| -Depreciation | ---- | 2.46%99.67M | ---- | 11.54%97.28M | ---- | 2.49%87.21M | ---- | 14.29%85.1M | ---- | -15.41%74.46M |
| Financial expense | ---- | -19.85%29.7M | ---- | -62.50%37.05M | ---- | -61.47%98.8M | ---- | 49.94%256.43M | ---- | 8.64%171.01M |
| Operating profit before the change of operating capital | ---- | -16.92%459.02M | ---- | 20.41%552.49M | ---- | 101.46%458.83M | ---- | 55.01%227.75M | ---- | -53.39%146.93M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -171.81%-39.35M | ---- | 185.09%54.8M | ---- | 36.49%-64.4M | ---- | -141.15%-101.41M | ---- | 3,238.89%246.43M |
| Accounts receivable (increase)decrease | ---- | 122.65%114.67M | ---- | -442.82%-506.18M | ---- | 67.03%-93.25M | ---- | -261.72%-282.8M | ---- | -77.79%174.86M |
| Accounts payable increase (decrease) | ---- | -108.78%-6.39M | ---- | 43.37%72.8M | ---- | -83.12%50.78M | ---- | 142.42%300.8M | ---- | 26.02%-709.18M |
| Special items for working capital changes | ---- | -477.51%-129.24M | ---- | 42.61%-22.38M | ---- | -694.50%-38.99M | ---- | --6.56M | ---- | ---- |
| Cash from business operations | -43.42%239.01M | 163.12%398.71M | 1,397.49%422.42M | -51.58%151.53M | -114.83%-32.56M | 107.38%312.97M | 120.60%219.52M | 207.07%150.91M | 132.83%99.51M | -203.67%-140.95M |
| Other taxs | 6.08%-17.06M | 10.04%-74.85M | -59.03%-18.17M | -27.91%-83.2M | -11.92%-11.42M | 42.47%-65.05M | 74.50%-10.21M | -228.26%-113.08M | -296.62%-40.03M | 44.66%-34.45M |
| Net cash from operations | -45.10%221.95M | 373.98%323.85M | 1,019.16%404.26M | -72.44%68.33M | -121.01%-43.98M | 555.27%247.92M | 251.91%209.31M | 121.57%37.83M | 118.99%59.48M | -337.94%-175.4M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 53.12%9.22M | 67.83%13.96M | 66.39%6.02M | 16.55%8.32M | -9.26%3.62M | 8.15%7.14M | 58.21%3.99M | -31.47%6.6M | -74.22%2.52M | -11.92%9.63M |
| Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -77.49%25.39M | -53.85%133.05M |
| Sale of fixed assets | 7.52%28.75M | -66.62%57.1M | -59.42%26.74M | 11,738.96%171.07M | 56.31%65.9M | -98.84%1.45M | -0.31%42.16M | 4,379.95%124.68M | 1,992.68%42.29M | 624.74%2.78M |
| Purchase of fixed assets | 4.03%-66.65M | -75.27%-129.37M | -21.59%-69.45M | 0.92%-73.81M | 33.11%-57.12M | 41.59%-74.5M | -36.61%-85.39M | -77.20%-127.53M | -82.99%-62.5M | -19.81%-71.97M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --2.57M | ---- | ---- | ---- |
| Recovery of cash from investments | -38.46%80K | 307,243.85%799.09M | 0.00%130K | -82.92%260K | 0.00%130K | -98.11%1.52M | -99.87%130K | -91.96%80.32M | -88.80%97M | 27.62%998.98M |
| Cash on investment | ---- | ---850.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.85%-800M |
| Other items in the investment business | -33.01%12.82M | 14.45%43.6M | 0.39%19.14M | 0.21%38.1M | 0.37%19.06M | -13.41%38.02M | -43.29%18.99M | 114.66%43.91M | 111.22%33.49M | -268.11%-299.55M |
| Net cash from investment operations | 9.42%-15.78M | -145.76%-65.86M | -155.13%-17.42M | 645.82%143.94M | 280.07%31.6M | -120.61%-26.37M | -112.70%-17.55M | 572.62%127.98M | 189.24%138.2M | -111.21%-27.08M |
| Net cash before financing | -46.70%206.17M | 21.54%257.99M | 3,223.68%386.84M | -4.19%212.27M | -106.46%-12.38M | 33.61%221.54M | -2.99%191.76M | 181.89%165.81M | 142.23%197.68M | -164.23%-202.47M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1.24%340.35M | 13.04%1.07B | -24.78%336.19M | 11.11%947.46M | -11.91%446.94M | 14.81%852.7M | -40.24%507.35M | -53.66%742.73M | -23.54%849.03M | 59.44%1.6B |
| Refund | -51.68%-433.43M | 16.88%-941.66M | 41.84%-285.76M | -34.37%-1.13B | 16.11%-491.36M | 1.21%-843.07M | 34.86%-585.72M | 45.08%-853.42M | -13.58%-899.17M | -99.90%-1.55B |
| Issuing shares | ---- | --55.66M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -33.11%-599K | 52.12%-824K | 52.58%-450K | 25.75%-1.72M | 25.74%-949K | 15.40%-2.32M | 8.19%-1.28M | 1.83%-2.74M | 0.57%-1.39M | 13.05%-2.79M |
| Other items of the financing business | 14.41%-11.39M | -99.60%340K | 27.33%-13.31M | 205.51%85.83M | 75.06%-18.31M | -94.22%-81.35M | 16.67%-73.42M | 40.97%-41.89M | 6.86%-88.11M | 28.25%-70.96M |
| Net cash from financing operations | -423.76%-109.97M | 244.26%169.88M | 147.69%33.97M | -32.47%-117.77M | 56.12%-71.23M | 49.71%-88.9M | -6.83%-162.33M | -249.42%-176.76M | -172.28%-151.95M | -147.55%-50.59M |
| Effect of rate | -108.05%-43K | -92.42%20K | 103.04%534K | -24.14%264K | 101.76%263K | 127.10%348K | -223.44%-14.97M | -310.22%-1.28M | -1,044.49%-4.63M | -400.96%-313K |
| Net Cash | -77.14%96.2M | 352.78%427.88M | 603.26%420.8M | -28.76%94.5M | -384.09%-83.62M | 1,311.37%132.65M | -35.64%29.43M | 95.67%-10.95M | 117.73%45.73M | -160.02%-253.06M |
| Begining period cash | 78.05%976.16M | 20.90%548.26M | 20.90%548.26M | 41.49%453.5M | 41.49%453.5M | -3.68%320.5M | -3.68%320.5M | -43.23%332.74M | -43.23%332.74M | 256.56%586.11M |
| Cash at the end | 10.59%1.07B | 78.05%976.16M | 161.95%969.6M | 20.90%548.26M | 10.50%370.15M | 41.49%453.5M | -10.40%334.97M | -3.68%320.5M | 13.72%373.84M | 1,822.79%332.74M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Furui Mazze Certified Public Accountants Co., Ltd. | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.